3D Endoanal Ultrasound and Anal Fistula
UFU
The Role of 3D Endoanal Ultrasound in Management of Anal Fistulas
1 other identifier
observational
95
1 country
1
Brief Summary
The study aims to evaluate the use of 3D endoanal ultrasound in preoperative management of anal fistula disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
April 29, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 24, 2023
CompletedFebruary 28, 2024
February 1, 2024
2 years
April 29, 2019
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Fistula position
Dorsal? Ventral? Lateral - right or left?
Day 1
Fistula level
Level I-IV (how much of the sphincter is affected?)
Day 1
Fistula length
Shorter or longer than 3 cm?
Day 1
Study Arms (1)
Anal fistula
Patients with anal fistulas, no previous fistula procedures. Ultrasound investigation done as a part of surgical treatment, such as loose seton or fistulotomy.
Interventions
Endoanal ultrasound performed with two different transducers preoperatively during a fistula treatment procedure.
Eligibility Criteria
Patients with newly diagnosed anal fistula with no previous anal fistula procedures.
You may qualify if:
- anal fistula
- no previous fistula procedures
You may not qualify if:
- previous fistula procedures
- ano/rectovaginal fistula
- inflammatory bowel disease
- more than one internal openings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Pelvic Floor Centre
Malmo, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ursula Aho Fält, MD
Region Skane
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2019
First Posted
May 6, 2019
Study Start
April 1, 2018
Primary Completion
March 26, 2020
Study Completion
January 24, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02